Generalized epilepsy with febrile seizures plus

File:Sodium channel beta GEFS plus.png

File:GABRG2 GEFS plus.png

File:SCN2A GEFS plus.png

Generalized Epilepsy with Febrile Seizures Plus (GEFS+) is a genetic disorder characterized by a spectrum of seizure types, ranging from simple febrile seizures to more severe forms of epilepsy. The condition is notable for its variability, even within the same family, and for the fact that individuals may outgrow febrile seizures but develop other types of seizures later in life.

Etiology and Genetics

GEFS+ is primarily inherited in an autosomal dominant manner, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder. Several genes have been associated with GEFS+, including SCN1A, SCN1B, SCN2A, GABRG2, and STX1B, all of which play crucial roles in the function of neurons in the brain. Mutations in these genes affect the regulation of ion channels, leading to the hyperexcitability of neurons that underlies seizures.

Clinical Features

The defining feature of GEFS+ is the broad spectrum of seizure types it encompasses. Affected individuals typically present with febrile seizures in early childhood. However, unlike typical febrile seizures that resolve by age 6, individuals with GEFS+ may continue to experience febrile seizures beyond this age or develop other seizure types, including:

• Absence seizures
• Myoclonic seizures
• Atonic seizures
• Tonic-clonic seizures

The severity and frequency of seizures can vary widely among individuals with GEFS+, even among members of the same family.

Diagnosis

Diagnosis of GEFS+ is based on clinical history, seizure types, and the age of onset. Genetic testing can confirm a diagnosis by identifying mutations in the associated genes. However, not all individuals with the clinical features of GEFS+ will have an identifiable genetic mutation, suggesting that other genes or factors may also be involved.

Treatment

Treatment for GEFS+ focuses on managing seizures through medication. The choice of antiepileptic drugs (AEDs) depends on the types of seizures an individual experiences. In some cases, multiple AEDs may be necessary to control seizures. The effectiveness of treatment can vary, and some individuals may achieve seizure control with medication, while others may continue to experience seizures despite treatment.

Prognosis

The prognosis for individuals with GEFS+ varies. Some may outgrow their seizures in adolescence, while others may continue to experience seizures into adulthood. The development of more severe epilepsy forms, such as status epilepticus, can occur but is not common.

Research Directions

Research on GEFS+ continues to focus on identifying new genetic mutations associated with the disorder and understanding how these mutations affect neuronal function. There is also ongoing research into developing more effective treatments and interventions for managing seizures in individuals with GEFS+.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian